BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19929730)

  • 1. Previous studies underestimate BMAA concentrations in cycad flour.
    Cheng R; Banack SA
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():41-3. PubMed ID: 19929730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands.
    Banack SA; Murch SJ; Cox PA
    J Ethnopharmacol; 2006 Jun; 106(1):97-104. PubMed ID: 16457975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the neurotoxin BMAA (beta-N-methylamino-L-alanine) in cycad seed and cyanobacteria by LC-MS/MS (liquid chromatography tandem mass spectrometry).
    Rosén J; Hellenäs KE
    Analyst; 2008 Dec; 133(12):1785-9. PubMed ID: 19082084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery of BMAA, and examples of biomagnification and protein incorporation involving other non-protein amino acids.
    Bell EA
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():21-5. PubMed ID: 19929727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China.
    Li A; Tian Z; Li J; Yu R; Banack SA; Wang Z
    Toxicon; 2010 May; 55(5):947-53. PubMed ID: 19822166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans.
    Cox PA; Richer R; Metcalf JS; Banack SA; Codd GA; Bradley WG
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():109-17. PubMed ID: 19929742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.
    Duncan MW; Steele JC; Kopin IJ; Markey SP
    Neurology; 1990 May; 40(5):767-72. PubMed ID: 2330104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of BMAA neurotoxicity: a critical review.
    Karamyan VT; Speth RC
    Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Content of the neurotoxins cycasin (methylazoxymethanol beta-D-glucoside) and BMAA (beta-N-methylamino-L-alanine) in cycad flour prepared by Guam Chamorros.
    Kisby GE; Ellison M; Spencer PS
    Neurology; 1992 Jul; 42(7):1336-40. PubMed ID: 1620343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC-MS/MS determination of the isomeric neurotoxins BMAA (beta-N-methylamino-L-alanine) and DAB (2,4-diaminobutyric acid) in cyanobacteria and seeds of Cycas revoluta and Lathyrus latifolius.
    Krüger T; Mönch B; Oppenhäuser S; Luckas B
    Toxicon; 2010; 55(2-3):547-57. PubMed ID: 19825383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG; Mash DC
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMAA selectively injures motor neurons via AMPA/kainate receptor activation.
    Rao SD; Banack SA; Cox PA; Weiss JH
    Exp Neurol; 2006 Sep; 201(1):244-52. PubMed ID: 16764863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ; Cox PA; Banack SA; Steele JC; Sacks OW
    Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing the cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) from other diamino acids.
    Banack SA; Metcalf JS; Spáčil Z; Downing TG; Downing S; Long A; Nunn PB; Cox PA
    Toxicon; 2011 Apr; 57(5):730-8. PubMed ID: 21329717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for non-protein amino acids in seeds of the Guam cycad, Cycas circinalis, by an improved GC-MS method.
    Oh CH; Brownson DM; Mabry TJ
    Planta Med; 1995 Feb; 61(1):66-70. PubMed ID: 7700995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
    Pablo J; Banack SA; Cox PA; Johnson TE; Papapetropoulos S; Bradley WG; Buck A; Mash DC
    Acta Neurol Scand; 2009 Oct; 120(4):216-25. PubMed ID: 19254284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam.
    Murch SJ; Cox PA; Banack SA
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyanobacteria (Nostoc commune) used as a dietary item in the Peruvian highlands produce the neurotoxic amino acid BMAA.
    Johnson HE; King SR; Banack SA; Webster C; Callanaupa WJ; Cox PA
    J Ethnopharmacol; 2008 Jun; 118(1):159-65. PubMed ID: 18495396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam.
    Banack SA; Cox PA
    Neurology; 2003 Aug; 61(3):387-9. PubMed ID: 12913204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The non-protein amino acid β-N-methylamino-L-alanine in Portuguese cyanobacterial isolates.
    Cervantes Cianca RC; Baptista MS; Lopes VR; Vasconcelos VM
    Amino Acids; 2012 Jun; 42(6):2473-9. PubMed ID: 21863230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.